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INTRODUCTION
Most of the world’s adult population exhibits partial
lactose maldigestion as a result of the physiological
decline in intestinal lactase, and may suffer from
intolerance symptoms following lactose ingestion.1 It
is now well established that lactase deficient subjects
tolerate lactose better from yoghurt, even from pasteur-
ized yoghurt,2, 3 than from other dairy products.4 The
mechanisms of this improved tolerance are poorly
understood, but the following three mechanisms have
at least been involved: (i) stimulation of endogenous
lactase, which has not been shown to be relevant in
humans,5 (ii) the presence of b-galactosidase released
from yoghurt-producer organisms, which only occurs if
the culture is still alive in the yoghurts,6 and (iii)
delayed gastric emptying and orocoecal transit time.7
The rapid gastric emptying and small bowel transit of a
lactose load seems to induce appreciable gastrointestinal
symptoms in most lactose malabsorbers. However, an
accurate assessment of lactose intolerance manifesta-
tions, such as flatulence, abdominal bloating and pain,
nausea or diarrhoea requires double-blind testing.8
The purpose of this study was to determine whether
subjects with lactose malabsorption have fewer
symptoms of intolerance and better absorption of lactose
after the ingestion of yoghurt when compared with
SUMMARY
Background: The relationship of symptoms with objec-
tive measurements, as well as some of the mechanisms
involved in lactose tolerance after yoghurt consump-
tion, remain unclear.
Methods: The trial had a double-blind design in which
22 lactose malabsorbers received 25 g daily lactose in
fresh (living bacteria > 108 cfu/g) yoghurt or heated
(< 102 cfu/g) yoghurt for 15 days, followed by a cross-
over (15 days) after a wash-out period (14 days). The
lactose digestion was determined by the breath H2 test,
the gastric emptying (GE) with a 13C-acetate breath test
and the revealed transit time (OCTT) by 15N-lactose-
ureide test. Subjects reported their gastrointestinal
symptoms (GIS) in a validated questionnaire.
Results: Breath H2 test indicated more effective lactose
digestion after fresh yoghurt intake. The OCTT was
shorter after heated yoghurt ingestion as compared with
the fresh. There was lower severity of GIS (P < 0.05)
after fresh yoghurt intake, and this showed an inverse
correlation with OCTT (P < 0.05).
Conclusions: Delayed orocoecal transit time was associ-
ated with fewer gastrointestinal symptoms. The
improved lactose digestion and tolerance of fresh
yoghurt should be mainly attributed to the presence of
living bacteria.
Correspondence to: Dr J. Alfredo Martı´nez, Department of Physiology and
Nutrition, University of Navarra, Irunlarrea street s/n, 31008 Pamplona,
Spain.
E-mail: jalfmtz@unav.es
Aliment Pharmacol Ther 2001; 15: 543–549.
Ó 2001 Blackwell Science Ltd 543
pasteurized yoghurt, in order to evaluate the possible
mechanisms involved in this response. In addition, this
trial aimed to elucidate the relationship between lactose




Volunteers (n  182) were recruited through advertise-
ments displayed at the University of Navarra. Subjects
were excluded if they had undergone gastrointestinal
surgery, had other major illness, drank excessive
amounts of alcohol, had peptic ulcer disease, received
antibiotic therapy within the previous three months, or
were smokers. Thirty-one were found to be maldigesters
as identified by rises in breath-hydrogen concentration
above baseline (fasting value) > 20 p.p.m. in a 3 h
period after the ingestion of a 200 mL aqueous solution
containing 25 g lactose. Twenty-two subjects
(12 women and 10 men, mean age 21.8  1.6 years)
were selected to participate in this study. Four were
withdrawn for personal reasons as the study proceeded.
Participants had normal haematologic indexes (white
blood cells counts, haemoglobin, haematocrit, mean
corpuscular volume and platelet counts), normal serum
albumin concentration, and normal values from tests of
liver (alkaline phosphatase, total bilirrubin and
transaminases) and kidney (blood urea nitrogen and
creatinine concentration) functions. Written informed
consent was obtained from all subjects and the study
protocol was approved by the Ethical Committee of the
Health Department of Navarra.
Dairy products
Two test meals which had been produced and processed
at the D. Carasso Research Center in Paris (France) were
given to the subjects: (i) yoghurt containing active live
cultures and (ii) pasteurized yoghurt, made from the
same skimmed milk and whose lactose concentration,
pH and viscosity were similar (Table 1). The nonpas-
teurized yoghurt contained at least 108 colony forming
units (CFU/g) each of Lactobacillus bulgaricus and
Stroptococcus thermophilus. The fresh and heated
yoghurts were stored at 4 °C and ingested between
day 8 and day 24 after their production, following
routine procedures for transport and storage.
Study design
The subjects were invited to attend a meeting where
they were given detailed instructions about the study
and the tests meals to be eaten at home. A double-blind,
crossover design was used (Figure 1). The fresh or
heated yoghurts were consumed in random order, with
a 14-day wash-out period between each dairy product
intake period (15 days). The H group (7 women and 4
men) begun the study with the heated yoghurt intake
period, and the F group (5 women and 6 men) started
with the fresh yoghurt intake period.
In the morning on days 1 (D1), 15 (D15), 30 (D30)
and 44 (D44) after a 12-h fast, breath H2 and serum
glucose were measured at baseline and after ingestion of
4 units of test yoghurts (25 g lactose), and the
volunteers scored their gastrointestinal symptoms at
the conclusion of the 7 h test period. On days 15 and
44, at the end of each yoghurt intake period, gastric
emptying, orocoecal transit time (OCTT) and faecal
weight and frequency were measured. Just before being
consumed, 1 g 15N-lactose-ureide (99 atom %) and
150 mg 13C-acetate (99 atom %) were added to one
Table 1. Composition and characteristics of the two yoghurts per
test dose (500 mL)*
Product
Fresh yoghurt Heated yoghurt
pH 4.11  0.11 4.17  0.02
Lactose (g) 25.7  1.1 25.5  1.1
L. bulgaricus
(CFU/g)
1.75 · 108  3.4 · 108 < 15
S. thermophilus
(CFU/g)
5.93 · 108  1.38 · 108 < 15
* Values are mean  S.E.M.
Figure 1. Diagram of study design.
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yoghurt and then carefully stirred. From day 2 (D2) to
day 14 (D14) and from D31 to D43, the 4 units of test
yoghurts (25 g lactose) were consumed in two or three
intakes over the day, with half of the quantity at
dinnertime during the evening.
Dietary fibre was restricted the evening before testing.
A standard hamburger and rice meal, which did not
produce increases in hydrogen, was provided to all
subjects 4 h after they ingested the four test yoghurts,
to allow sampling follow-up over a 7 h period without
hunger.
Hydrogen analysis
Lactose absorption was assessed by breath hydrogen
analysis with portable equipment (EC60 Gastrolyser,
Isomed). End-alveolar breath samples obtained twice in
the fasting state were used, every 15 min for first 60 min
and each 30 min for the 7 h following ingestion of the
test meals. Changes in breath hydrogen concentration
(D) were calculated by subtracting the baseline (fasting)
hydrogen concentration from subsequent test values.
Labelled 13CO2 analysis
Gastric emptying was assessed by breath 13CO2 analysis
(Breath MATplus, Finnigan ThermoQuest) in the fasting
state, every 5 min for 30 min and each 15 min for 3 h
following ingestion of the test meal. The results of
breath 13CO2 measurements were expressed as a
percentage of the administered dose of 13C recovered
in the breath per hour1 (%13C dose/h) and as the
cumulative percentage of the administered dose of 13C
in the breath over 3 h (%13C cumulative dose) accord-
ing to Maes et al.9–12 Carbon dioxide production was
assumed to be 300 mmol/hxm2 body surface, and the
body surface area was calculated by using the formula
of Haycock et al.13 Using least-square algorithms, the
curves percentage 13C recovery were fitted to the
following two formulas:
%13C dose/h  atbeÿct 1
and
%13C cumulative dose  m1ÿ eÿktb 2
where t is time, and a, b, c, m, k and b are constants
determined by nonlinear-regression analysis. Three
parameters describing gastric emptying were calculated
from the constants obtained: (i) gastric emptying half
time t1/2  ()1/k)ln(1 ) 2)1/b), (ii) gastric emptying
coefficient GEC  ln a and (iii) the lag phase tlag  ln b/k.
Labelled 15N analysis
Orocoecal transit time (OCTT) was assessed through
urine 15NH3 output determination (Delta E, Finnigan
MAT). Urine was collected baseline, at 2 h intervals
over a period of 14 h after tracer administration, and a
final sample was obtained 23 h after ingestion of the
test yoghurts. The urine volumes were recorded, 2 mL
of each sample were acidified with 6N H2SO4 to attain a
pH < 4, and stored at )20 °C until analysis. The results
were expressed as the total urine 15N excretion over
time and the OCTT was calculated as the point of
inflexion of the obtained curve.14
Gastrointestinal symptoms
The occurrence and severity of symptoms (flatulence,
abdominal bloating and pain) was recorded by the
subjects and self-rated on a scale of 0–4 on each test day
after the 7 h experimental period as follows: 0  no
symptoms, 1  mild symptoms, 2  moderate symp-
toms, 3  severe symptoms and 4  intolerable symp-
toms.15 The number of points for each category was
totalled to determine the total symptom score.
Statistical analysis
Data were expressed as means  S.E.M. The lack of
differences between the two groups (F and H groups) due
to the randomization, led us to present the results as fresh
or heated test days (D1: the first day of fresh or heated
yoghurt intake period, and D15: the last day of treatment
period). Differences in breath hydrogen concentration
results and in GEC, t1/2, tlag and OCTT values between the
fresh or heated yoghurt intake days were evaluated by
using paired Student’s t-tests. Intolerance symptoms after
fresh or heated yoghurt intake in each experimental day
were compared by the Wilcoxon signed-rank test. The
correlation between lactose digestion, gastric emptying
parameters, OCTT and intolerance symptoms were
calculated using the Spearman rank order test. Results
were considered statistically significant if two-sided
P-values were < 0.05. All statistical analysis were
performed by using the SPSS 7.5 version for Windows.
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RESULTS
Breath hydrogen excretion and biochemical analysis
The mean changes in breath hydrogen concentration
for the measured 7 h period (Figure 2) indicated a more
effective lactose digestion after fresh yoghurt intake as
compared to heated yoghurt. Indices of H2 excretion
were compared among the two experimental days,
before and after 4 units of dairy product intake, in three
ways: (i) mean peak rise above fasting baseline levels
seen in each study subjects (Peak H2) (ii) cumulative H2
excretion over the 7 h period (H2 cum), and (iii) the
area under the curve of H2 excretion calculated by a
trapezoidal method (H2 AUC). Fresh yoghurt ingestion
resulted in lower peak H2, H2 cum and AUC H2 than
pasteurized yoghurt intake, indicating a more effective
lactose digestion (Table 2).
Serum glucose, insulin and free fatty acid (FFA)
concentrations measured over the 7 h period were
similar after heated or fresh yoghurt intake treatment.
Gastrointestinal symptoms
Overall, the lactose malabsorbers exhibited few symp-
toms during the two study periods (Figure 3). Thus, the
mean symptom-severity scores were between 0.5 and
Figure 2. Changes in breath hydrogen
concentration before (D1) and after (D15)
25 g lactose load intake treatment as fresh
or heated yoghurt. n  18 lactose malab-
sorber subjects.
Dairy intake
Heated yoghurt Fresh yoghurt
D15 D15 P
Peak H2 (p.p.m.)  47.6  6.8 17.2  3.8 0.001
a
H2 cum (p.p.m.)  116.2  57.2 )68.8  43.2 0.013
a
AUC H2 (p.p.m.min)  3605.0  1696.9 )1752.8  1190.4 0.012
a
AUC glucose (mmol/L.min)  )58.5  20.5 )45.4  19.3 0.575
AUC insulin (mU/L.min)  1742.4  205.9 1822.9  694.0 0.908
AUC FFA (mmol/L.min) 52.58  3.29 54.70  3.64 0.482
tlag (min)  48.48  4.80 50.55  5.37 0.722
t1/2 (min)  95.08  4.59 90.16  3.96 0.377
OCTT (h)  12.1  0.5 10.5  0.6 0.054ts
GIS  2.6  0.5 1.4  0.3 0.037a
* Abbreviations used: Peak H2: peak of hydrogen excretion; H2 cum: summation of the breath
H2 concentration over 7 h; AUC H2: area under curve for breath H2 excretion; t1/2: gastric
emptying half time; tlag: lag phase; OCTT: orocoecal transit time; GIS: gastrointestinal symp-
toms score expressed as the mean of the sum of flatulence, abdominal pain and bloating scored
rated from 0 to 4 (none to intolerable); AUC glucose: area under curve for blood glucose
concentration; AUC insulin: area under curve for serum insulin concentration; AUC FFA: area
under curve for serum free fatty acid concentration.
  n = 19. Values are mean  S.E.M.
a Significantly different between the two test groups, P < 0.05 (paired Student’s t-test or
Wilcoxon rank test when appropriate).
ts marginal significance 0.05 < P < 0.1 (two-sided).
Table 2. Parameters describing lactose
digestion, gastric emptying, orocoecal
transit time and gastrointestinal symptoms
at final of each test yoghurts intake period*
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3.0, indicating symptoms of mild severity. Nevertheless,
there was a significantly lower severity of scored
symptoms after yoghurt containing active live cultures
than after ingestion of pasteurized yoghurt (Table 2).
The highest symptom score in both groups was for
flatulence, and others such as nausea or diarrhoea were
rare during either intervention period. On the other
hand, the regular ingestion of 25 g lactose did not result
in significant decreases in breath hydrogen indices and
lactose intolerance symptoms, as revealed by the results
before and 15 days after 25 g lactose ingestion as
heated yoghurt intake treatment (data not shown).
Faecal weight and frequency
Faecal weight and frequency measured at the end of
each yoghurt intake period was not significantly
different between the two test yoghurt intakes, i.e.
86.2  17.4 g/1 day and 1.2  0.1 no. faeces/day for
fresh yoghurt and 88.0  14.9 g/1 day and 1.2  0.2
no. faeces/day for heated yoghurt.
Gastric emptying and orocoecal transit time
Gastric emptying half time (t1/2) and tlag were unaffec-
ted after fresh or heated yoghurt ingestion (Table 2).
However, OCTT was shorter after pasteurized yoghurt
(10.5  0.6 h) than after fresh yoghurt ingestion
(12.1  0.5 h) and showed a significant negative
correlation with the gastrointestinal symptoms score
(GIS) according to Spearman rank correlation
(r  )0.413; P  0.014).
DISCUSSION
A number of studies have demonstrated that lactose
tolerance is enhanced when consumed as yoghurt
containing active live cultures, as compared with other
dairy products.16 Pasteurization of yoghurt, which
results in a virtual elimination of b-galactosidase
activity, could also reduce most beneficial effects on
lactose digestion.17 Nevertheless, several investigators
have found that heated yoghurt retains some capacity
to alleviate lactose intolerance symptoms.2, 5 Thus, a
slower gastric emptying and orocoecal transit time,
probably due to osmolality and/or the physical form of
both dairy products, have been associated with less
severe symptoms of lactose intolerance.6, 18, 19
Data from this study showed that lactose malabsorber
subjects digest lactose more effectively in fresh yoghurt
than in pasteurized yoghurt.20, 21 The subjects consu-
ming 4 units of fresh yoghurt (25 g lactose) no longer
appeared to be lactose maldigesters on the basis of
breath hydrogen criteria, in the two experimental
groups. As a result of this improved lactose digestion
from yoghurt containing living bacterial, the lactose
was apparently better tolerated than the other dairy
products tested.
In this study, gastric emptying was similar between the
two test yoghurts (fresh and heated), while the orocoe-
cal transit time of fresh yoghurt was markedly slower
than that of the heated yoghurt. Furthermore, gastro-
intestinal symptoms displayed a strong inverse correla-
tion with OCTT. These findings suggest that when
intestinal transit time increases, lactose digestion and
tolerance may improve.22
Other researchers have compared lactose tolerance
and gastric emptying between different test milks,
taking into account the milk viscosity or energy
content.23, 24 They concluded that, in lactose maldi-
gesters, raising the viscosity of the milk to a level that
was similar to that of yoghurt did not affect lactose
tolerance or gastric emptying, and that raising the
energy content of milk slowed down gastric emptying of
lactose, but did not improve tolerance. Furthermore,
other reports have revealed that longer transit time
values were associated with fewer gastrointestinal
symptoms.25 However, this effect was not observed in
all studies.26 Interestingly, the slowing down of OCTT
by loperamide was associated with less severe symptoms
of lactose intolerance, which seems to argue in favour
of a direct link between motility and symptoms.25
Figure 3. Gastrointestinal symptoms (flatulence, abdominal pain
and bloating) on a scale from 02 (no symptoms) to 4 (intolerable
symptoms), before (D1) and after (D15) 25 g lactose load intake
treatment as fresh or heated yoghurt. GIS was significantly fewer
after fresh yoghurt intake as compared to the heated product (D15
yoghurt), P < 0.05. Results are as mean  S.E.M.
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However, it does not establish whether this link is
causative, and if so, which factor is the cause or the
consequence. Other authors have shown that in some
individuals, lactose digestion (presumably due to the
residual mucosal mammalian lactase) from pasteurized
yoghurt is slightly improved compared with that from
milk, as estimated by small reductions in overall gas
production.4, 17 Furthermore, the appearance of gas-
eous symptoms depends not only on the residual lactase
capacity,27 but also on the balance between the
production and the removal of these fermentation
products, which depends on colonic flora composition.9
The unusual tolerance observed in this trial may be
due to the lactose test dose assayed, which was more
physiological than in previous studies.9, 28, 29 The lack
of diarrhoea or headache in these lactose maldigester
subjects indicated that the colon removed the bulk of
the osmolar load provided by the malabsorbed lactose.30
The excessive flatus observed with pasteurized yoghurts
indicates that gas removal mechanisms were over-
whelmed by the rate of gas production; however, this
excess gas did not accumulate to the extent that
subjects recorded increased bowel movement frequen-
cies or stool weight. In this context, several controlled
studies have shown that one cup of milk or its lactose
equivalent (12 g) produces minimal symptoms, if any,
in lactose deficient subjects, and that fermented dairy
products are better tolerated than other dairy prod-
ucts.31–35
On the other hand, receiving fresh yoghurt for 15 days
did not result in any significant change in breath H2 test
data and in the scored gastrointestinal symptoms, when
lactose is consumed in subsequent experimental days as
pasteurized yoghurt, suggesting the absence of a
prolonged intestinal survival by the yoghurt micro-
organisms.36
Previous studies have reported colonic adaptation to
regular lactose ingestion, improving lactose tolerance
via several mechanisms.10 However, the lack of differ-
ences in the results between the first day (D1) and
15 days after receiving heated yoghurt showed that the
continuous ingestion of lactose did not appear to result
in significant reductions in breath hydrogen values or in
symptomatic response to lactose.37
In conclusion, these results indicate that the lactose
malabsorber subjects digest and tolerate better a lactose
load of 25 g in fresh yoghurt than in the pasteurized
yoghurt. The mechanism responsible for this enhanced
lactose digestion and tolerance was attributable to the
presence of bacterial b-galactosidase in the fresh
product. On the other hand, the slower mean transit
time induced by fresh yoghurt intake was associated
with fewer lactose intolerance symptoms. A recent
study concerning chronic consumption of fresh yoghurt
confirms the benefits on breath hydrogen status in men
with lactose maldigestion.38
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